Bringing 30+ years in biopharma, CROs, and medical devices, Dave has experience overseeing programs to support value messages across stakeholder groups for rare disease therapeutics. His previous roles include leadership positions at Genzyme, Quintiles, and PPD.
Dave Wilson, Chief Strategy Officer
Genzyme, Quintiles, PPD
